While over half of prostate cancers display fusions involving the oncogenic ETS transcription factors (including ETS1), ETS1 has been described in several patients with prostate cancer involved in fusion with HERV-K17 [272] and HERV-K_22q11.3 [271,280]. This evidence concerns the gene KRT17 and Familial prostate cancer.